N-(tert-Butyl)-6-(4-methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide, 98%, 1g

Récipient à col large, 120 ml, 100 Pièce(s)

1-PHENYL-2,5,8,11-TETRAOXATRIDECAN-13-YL 4-METHYLBENZENESULFONATE, 95%, 5g

3-Bromo-4-chloro-5-fluorobenzoic acid, 97%, 1g

Ethyl 3-hydroxypicolinate, 95.0%, 5g

1-[4-(Trifluoromethyl)phenyl]-1H-imidazole-5-carboxylic acid, 1g

Chloridazon>98.0%(GC)1g

2,2'-(4,5,6-Trifluorobenzene-1,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 97%, 1g

[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

3',5'-Dimethyl-2'-hydroxyacetophenone, 98.0%, 500g

2,4-Dibromo-m-xylene, 97.0%, 100g

ROTI®Pol ProofRead, 200 µl, 5 x 40 µl

2,3,6-TRIFLUORO-5-NITROBENZOIC ACID, 95.0%, 100mg